PE Owners Mull $1.2B Sale Of Medpace Clinical Research Unit

Law360, New York (November 15, 2013, 2:40 PM EST) -- The private equity firm behind Medpace Inc. is preparing to exit the clinical research company in a deal expected to bring in up to $1.2 billion, a source familiar with the situation told Law360 on Friday.

New York-based CCMP Capital Advisors LLC, which holds an 80 percent Medpace stake, has recruited investment bank Jefferies Group LLC to vet prospective bidders and run an auction for the company, the source confirmed.

Such a sale would provide CCMP a path out of Medpace less than three years after...
To view the full article, register now.